News

Under the agreement, which was announced in November 2008, AstraZeneca receives approximately $220 million for the divestiture. The over-the-counter (OTC) brands, predominantly sold in Sweden, include analgesics Alvedon

China Biologic Products, a plasma-based biopharmaceutical company, has reported a net income of $11.98m, or $0.56 per diluted share, for 2008, an increase of 46.5%, compared to $8.18m,

In addition, the companies have established oncology collaboration for two Bristol-Myers Squibb products – Sprycel (dasatinib) and Ixempra (ixabepilone). Under terms of the agreement Bristol-Myers Squibb will pay

Pursuant to Prescription Drug User Fee Act guidelines, Santarus expects the FDA will complete its review or otherwise respond to the new drug application (NDA) by December 4,

For the full year 2008, the company reported a net loss and comprehensive loss of $25.99 million, or $1.35 per share, compared to a net loss and comprehensive

Enzo Clinical Labs is a regional laboratory serving the greater New York/New Jersey area. Kevin Krenitsky, president of Enzo Clinical Labs, said: “As we continue to develop our

The company plans to use the net proceeds from the offering primarily for activities relating to preparations for the potential commercial launch of pralatrexate, clinical and preclinical R&D

Morris Rosenberg joined Seattle Genetics in July 2001 and has overseen significant growth of the company’s development organization, including the process development, quality assurance and control, analytical biochemistry,

“I am pleased to accept this new challenge and honoured to become a part of Solvay’s strong Canadian team,” said Hayter. “I firmly believe in Solvay’s passion for